Source: Annual Congress 2013 –COPD biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Steer, C. Echeverria, J. Gibson, S. Bourke (North Shields, Newcastle-upon-Tyne, United Kingdom). Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD. Eur Respir J 2013; 42: Suppl. 57, 2163

Member's Comments

No comment yet.

Related content which might interest you: Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 One-year mortality in COPD patients after severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Gender differences in hospitalized patients with acute exacerbation of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Cardiovascular risk assessment in COPD patients with severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Cardiovascular events (CVE) in COPD patients Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality Source: Annual Congress 2013 –COPD diagnosis Year: 2013 The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Outpatient care for reducing readmissions of patients hospitalized for exacerbation of COPD Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Statins and outcome of COPD patients after hospitalization for COPD exacerbations Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 Rehospitalizations for an acute exacerbation among patients with COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Vitamin D, exacerbations and hospitalizations in COPD patients Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Key factors associated with readmission in COPD patients Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Resting heart rate and exacerbations in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 Factors associated with cognitive dysfunction in COPD patients hospitalised with exacerbations Source: International Congress 2014 – COPD markers Year: 2014 The relation of comorbidities with the exacerbation severity in patients with COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013